Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data

Kimyon G., Kalyoncu U., Kiraz S., Bes C., COŞKUN N., Yagiz B., ...Daha Fazla

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.39, sa.4, ss.852-858, 2021 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 39 Sayı: 4
  • Basım Tarihi: 2021
  • Dergi Adı: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.852-858
  • Anahtar Kelimeler: leflunomide, methotrexate, rheumatoid arthritis, biologic or targeted-synthetic DMARDs, COMBINATION, THERAPY, MANAGEMENT, MONOTHERAPY
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Objective